Skip to main content
SpringerLink
Log in

Health Disparities

  • Chapter
  • First Online:
Cystic Fibrosis

Part of the book series: Respiratory Medicine ((RM))

  • 1453 Accesses

Abstract

The term “health disparities” denotes the potentially avoidable differences in health and health risks between disadvantaged social groups and the general population. Although the term is often used to indicate health differences based on race or ethnicity, disparities exist across many other dimensions, including socioeconomic status, geographic location, sexual orientation, and disability. The importance of these dimensions is particularly apparent in cystic fibrosis (CF).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BMI:

Body mass index

CF:

Cystic fibrosis

CFF:

Cystic Fibrosis Foundation

CFFPR:

Cystic Fibrosis Foundation Patient Registry

CFQ-R:

Cystic Fibrosis Questionnaire-Revised

CFTR:

Cystic fibrosis transmembrane regulator

CI:

Confidence interval

ECFSPR:

European Cystic Fibrosis Society Patient Registry

EU:

European Union

FEV1 :

Forced expiratory volume in 1 second

HR:

Hazard ratio

OR:

Odds ratio

SD:

Standard deviation

SES:

Socioeconomic status

References

  1. Braveman P. Health disparities and health equity: concepts and measurement. Annu Rev Public Health. 2006;27:167–94. https://doi.org/10.1146/annurev.publhealth.27.021405.102103.

    Article  PubMed  Google Scholar 

  2. NIH Health Disparities Strategic Plan and Budget, Fiscal Years 2009–2013: National Institute of Health; 2009.

    Google Scholar 

  3. Healthy People 2020: Office of Disease Prevention and Health Promotion 2010.

    Google Scholar 

  4. Brunner E, Marmot M. Social organization, stress and health. In: Marmot M, Wilkinson RG, editors. Social determinants of health. 2nd ed. Oxford, UK: Oxford University Press; 2006. p. 6–30.

    Google Scholar 

  5. House JS. Understanding social factors and inequalities in health: 20th century progress and 21st century prospects. J Health Soc Behav. 2002;43(2):125–42.

    PubMed  Google Scholar 

  6. House JS, Williams DR. Understanding and reducing socioeconomic and racial/ethnic disparities in health. In: Smedley BD, Syme SL, editors. Promoting health: intervention strategies from social and behavioral research. Washington, DC: National Academy Press; 2000. p. 81–124.

    Google Scholar 

  7. Kaplan GA. What is the role of the social environment in understanding inequalities in health? In: Adler NE, Marmot M, McEwen BS, Stewart J, editors. Socioeconomic status and health in industrialized nations. New York: Annals of the New York Academy of Sciences; 1999. p. 116–9.

    Google Scholar 

  8. Collaco JM, Blackman SM, McGready J, Naughton KM, Cutting GR. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr. 2010;157(5):802–7.e1-3. https://doi.org/10.1016/j.jpeds.2010.05.018.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Ratjen F, Doring G. Cystic fibrosis. Lancet. 2003;361(9358):681–9. https://doi.org/10.1016/S0140-6736(03)12567-6.

    Article  CAS  PubMed  Google Scholar 

  10. Collaco JM, Vanscoy L, Bremer L, et al. Interactions between secondhand smoke and genes that affect cystic fibrosis lung disease. JAMA. 2008;299(4):417–24. https://doi.org/10.1001/jama.299.4.417.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Corvol H, Blackman SM, Boelle PY, et al. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis. Nat Commun. 2015;6:8382. https://doi.org/10.1038/ncomms9382.

    Article  CAS  PubMed  Google Scholar 

  12. Wolfenden LL, Schechter MS. Genetic and non-genetic determinants of outcomes in cystic fibrosis. Paediatr Respir Rev. 2009;10(1):32–6. https://doi.org/10.1016/j.prrv.2008.04.002.

    Article  PubMed  Google Scholar 

  13. Krieger N, Williams DR, Moss NE. Measuring social class in US public health research: concepts, methodologies, and guidelines. Annu Rev Public Health. 1997;18:341–78. https://doi.org/10.1146/annurev.publhealth.18.1.341.

    Article  CAS  PubMed  Google Scholar 

  14. Oakes JM, Rossi PH. The measurement of SES in health research: current practice and steps toward a new approach. Soc Sci Med. 2003;56(4):769–84.

    PubMed  Google Scholar 

  15. Spilerman S. Wealth and stratification processes. Ann Rev Soc. 2000;26:497–524. https://doi.org/10.1146/annurev.soc.26.1.497.

    Article  Google Scholar 

  16. Braveman PA, Cubbin C, Egerter S, Williams DR, Pamuk E. Socioeconomic disparities in health in the United States: what the patterns tell us. Am J Public Health. 2010;100(Suppl 1):S186–96.

    PubMed  PubMed Central  Google Scholar 

  17. Kitagawa EM, Hauser PM. Differential mortality in the United States: a study in socioeconomic epidemiology. Cambridge, MA: Harvard University Press; 1973.

    Google Scholar 

  18. Pappas G, Queen S, Hadden W, Fisher G. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med. 1993;329(2):103–9. https://doi.org/10.1056/NEJM199307083290207.

    Article  CAS  PubMed  Google Scholar 

  19. Adler NE, Ostrove JM. Socioeconomic status and health: what we know and what we don’t. Ann N Y Acad Sci. 1999;896:3–15. https://doi.org/10.1111/j.1749-6632.1999.tb08101.x.

    Article  CAS  PubMed  Google Scholar 

  20. Britton JR. Effects of social class, sex, and region of residence on age at death from cystic fibrosis. BMJ. 1989;298(6672):483–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Barr HL, Britton J, Smyth AR, Fogarty AW. Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study. Br Med J. 2011;343 https://doi.org/10.1136/Bmj.D4662.

  22. Schechter MS, Shelton BJ, Margolis PA, Fitzsimmons SC. The association of socioeconomic status with outcomes in cystic fibrosis patients in the United States. Am J Respir Crit Care Med. 2001;163(6):1331–7.

    CAS  PubMed  Google Scholar 

  23. Schechter MS, Margolis PA. Relationship between socioeconomic status and disease severity in cystic fibrosis. J Pediatr. 1998;132(2):260–4.

    CAS  PubMed  Google Scholar 

  24. O’Connor GT, Quinton HB, Kneeland T, et al. Median household income and mortality rate in cystic fibrosis. Pediatrics. 2003;111(4):e333–9.

    PubMed  Google Scholar 

  25. Johnson B, Ngueyep R, Schechter MS, Serban N, Swann J. Does distance to a cystic fibrosis center impact health outcomes? Pediatr Pulmonol. 2018;53(3):284–92. https://doi.org/10.1002/ppul.23940.

    Article  PubMed  Google Scholar 

  26. Taylor-Robinson DC, Smyth RL, Diggle PJ, Whitehead M. The effect of social deprivation on clinical outcomes and the use of treatments in the UK cystic fibrosis population: a longitudinal study. Lancet Respir Med. 2013;1(2):121–8. https://doi.org/10.1016/S2213-2600(13)70002-X.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Taylor-Robinson DC, Thielen K, Pressler T, et al. Low socioeconomic status is associated with worse lung function in the Danish cystic fibrosis population. Eur Respir J. 2014;44(5):1363–6. https://doi.org/10.1183/09031936.00063714.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Macpherson C, Redmond AO, Leavy A, McMullan M. A review of cystic fibrosis children born to single mothers. Acta Paediatr. 1998;87(4):397–400.

    CAS  PubMed  Google Scholar 

  29. Sanders DB, Emerson J, Ren CL, et al. Early childhood risk factors for decreased FEV1 at age six to seven years in young children with cystic fibrosis. Ann Am Thorac Soc. 2015;12(8):1170–6. https://doi.org/10.1513/AnnalsATS.201504-198OC.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Britton LJ, Mims C, Harris WT, Brown J. Predictors of patient outcomes at 12 months of age in patients diagnosed by newborn screening (abstract). Pediatr Pulmonol. 2013;48(S36):372–3.

    Google Scholar 

  31. Sandman CA, Davis EP. Neurobehavioral risk is associated with gestational exposure to stress hormones. Expert Rev Endocrinol Metab. 2012;7(4):445–59. https://doi.org/10.1586/eem.12.33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Lu MC, Halfon N. Racial and ethnic disparities in birth outcomes: a life-course perspective. Matern Child Health J. 2003;7(1):13–30.

    PubMed  Google Scholar 

  33. Brunton PJ. Programming the brain and behaviour by early-life stress: a focus on neuroactive steroids. J Neuroendocrinol. 2015;27(6):468–80. https://doi.org/10.1111/jne.12265.

    Article  CAS  PubMed  Google Scholar 

  34. Zhu P, Sun MS, Hao JH, et al. Does prenatal maternal stress impair cognitive development and alter temperament characteristics in toddlers with healthy birth outcomes? Dev Med Child Neurol. 2014;56(3):283–9. https://doi.org/10.1111/dmcn.12378.

    Article  PubMed  Google Scholar 

  35. Sandman CA. Fetal exposure to placental corticotropin-releasing hormone (pCRH) programs developmental trajectories. Peptides. 2015;72:145. https://doi.org/10.1016/j.peptides.2015.03.020.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Smith R, Nicholson RC. Corticotrophin releasing hormone and the timing of birth. Front Biosci. 2007;12:912–8.

    CAS  PubMed  Google Scholar 

  37. Hayward MD, Gorman BK. The long arm of childhood: the influence of early-life social conditions on men's mortality. Demography. 2004;41(1):87–107.

    PubMed  Google Scholar 

  38. Lynch J, Smith GD, Hillemeier M, Shaw M, Raghunathan T, Kaplan G. Income inequality, the psychosocial environment, and health: comparisons of wealthy nations. Lancet. 2001;358(9277):194–200. https://doi.org/10.1016/S0140-6736(01)05407-1.

    Article  CAS  PubMed  Google Scholar 

  39. Cystic Fibrosis Foundation Patient Registry. 2013 Annual data report to center directors. Bethesda: Cystic Fibrosis Foundation; 2014.

    Google Scholar 

  40. Anthony H, Paxton S, Bines J, Phelan P. Psychosocial predictors of adherence to nutritional recommendations and growth outcomes in children with cystic fibrosis. J Psychosom Res. 1999;47(6):623–34.

    CAS  PubMed  Google Scholar 

  41. James WP, Nelson M, Ralph A, Leather S. Socioeconomic determinants of health. The contribution of nutrition to inequalities in health. BMJ. 1997;314(7093):1545–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Taylor-Robinson D, Whitehead M, Diggle P, Smyth R. The effect of social deprivation on weight in the UK cystic fibrosis population. J Epidemiol Community Health. 2011;65:A389-A. https://doi.org/10.1136/jech.2011.142976n.30.

    Article  Google Scholar 

  43. Pinto IC, Silva CP, Britto MC. Nutritional, clinical and socioeconomic profile of patients with cystic fibrosis treated at a referral center in northeastern Brazil. J Bras Pneumol. 2009;35(2):137–43.

    PubMed  Google Scholar 

  44. Balmer DF, Schall JI, Stallings VA. Social disadvantage predicts growth outcomes in preadolescent children with cystic fibrosis. J Cyst Fibros. 2008;7(6):543–50. https://doi.org/10.1016/j.jcf.2008.06.004.

    Article  PubMed  Google Scholar 

  45. Pearlin L. The sociological study of stress. J Health Soc Behav. 1989;30(3):241–56.

    CAS  PubMed  Google Scholar 

  46. Turner RJ, Wheaton B, Lloyd DA. The epidemiology of social stress. Am Sociol Rev. 1995;60(1):104–25. https://doi.org/10.2307/2096348.

    Article  Google Scholar 

  47. Thoits PA. Stress and health: major findings and policy implications. J Health Soc Behav. 2010;51(Suppl):S41–53. https://doi.org/10.1177/0022146510383499.

    Article  PubMed  Google Scholar 

  48. Pearlin L, Schieman S, Fazio EM, Meersman SC. Stress, health, and the life course: some conceptual perspectives. J Health Soc Behav. 2005;46(2):205–19. https://doi.org/10.1177/002214650504600206.

    Article  PubMed  Google Scholar 

  49. Evans GW, Kim P. Multiple risk exposure as a potential explanatory mechanism for the socioeconomic status-health gradient. Ann N Y Acad Sci. 2010;1186:174–89. https://doi.org/10.1111/j.1749-6632.2009.05336.x.

    Article  PubMed  Google Scholar 

  50. Thoits PA. Stress, coping, and social support processes: where are we? What next? J Health Soc Behav. 1995;Spec No:53–79.

    Google Scholar 

  51. Marmot MG, Bosma H, Hemingway H, Brunner E, Stansfeld S. Contribution of job control and other risk factors to social variations in coronary heart disease incidence. Lancet. 1997;350(9073):235–9.

    CAS  PubMed  Google Scholar 

  52. Harper S, Lynch J, Hsu WL, et al. Life course socioeconomic conditions and adult psychosocial functioning. Int J Epidemiol. 2002;31(2):395–403.

    PubMed  Google Scholar 

  53. Berkman LF, Kawachi I. Social epidemiology. New York: Oxford University Press; 2000.

    Google Scholar 

  54. Seeman TE, McEwen BS, Rowe JW, Singer BH. Allostatic load as a marker of cumulative biological risk: MacArthur studies of successful aging. Proc Natl Acad Sci U S A. 2001;98(8):4770–5. https://doi.org/10.1073/pnas.081072698.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  55. McEwen BS, Seeman T. Protective and damaging effects of mediators of stress. Elaborating and testing the concepts of allostasis and allostatic load. Ann N Y Acad Sci. 1999;896:30–47.

    CAS  PubMed  Google Scholar 

  56. Kubzansky LD, Kawachi I, Sparrow D. Socioeconomic status, hostility, and risk factor clustering in the Normative Aging Study: any help from the concept of allostatic load? Ann Behav Med. 1999;21(4):330–8.

    CAS  PubMed  Google Scholar 

  57. Patterson JM, Budd J, Goetz D, Warwick WJ. Family correlates of a 10-year pulmonary health trend in cystic fibrosis. Pediatrics. 1993;91(2):383–9.

    CAS  PubMed  Google Scholar 

  58. Everhart RS, Fiese BH, Smyth JM, Borschuk A, Anbar RD. Family functioning and treatment adherence in children and adolescents with cystic fibrosis. Pediatr Allergy Immunol Pulmonol. 2014;27(2):82–6. https://doi.org/10.1089/ped.2014.0327.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Cruz I, Marciel KK, Quittner AL, Schechter MS. Anxiety and depression in cystic fibrosis. Semin Respir Crit Care Med. 2009;30(5):569–78. https://doi.org/10.1055/s-0029-1238915.

    Article  PubMed  Google Scholar 

  60. Hodgkinson R, Lester H. Stresses and coping strategies of mothers living with a child with cystic fibrosis: implications for nursing professionals. J Adv Nurs. 2002;39(4):377–83.

    PubMed  Google Scholar 

  61. Quittner AL, Opipari LC, Regoli MJ, Jacobsen J, Eigen H. The impact of caregiving and role strain on family life: comparisons between mothers of children with cystic fibrosis and matched controls. Rehabil Psychol. 1992;37:275–90.

    Google Scholar 

  62. Bittman M, Hill T, Thomson C. The impact of caring on informal carers’ employment, income and earnings: a longitudinal approach. Aust J Soc Issues. 2007;42(2):255–72.

    Google Scholar 

  63. Vitaliano PP, Zhang J, Scanlan JM. Is caregiving hazardous to one's physical health? A meta-analysis. Psychol Bull. 2003;129:946–72.

    PubMed  Google Scholar 

  64. Pinquart M, Sorensen S. Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis. Psychol Aging. 2003;18:250–67.

    PubMed  Google Scholar 

  65. Schulz R, Beach SR. Caregiving as a risk factor for mortality: the Caregiver Health Effects Study. JAMA. 1999;282(23):2215–9.

    CAS  PubMed  Google Scholar 

  66. Hatzmann J, Heymans HS, Ferrer-i-Carbonell A, van Praag BM, Grootenhuis MA. Hidden consequences of success in pediatrics: parental health-related quality of life–results from the Care Project. Pediatrics. 2008;122(5):e1030–8. https://doi.org/10.1542/peds.2008-0582.

    Article  PubMed  Google Scholar 

  67. Neri L, Lucidi V, Catastini P, Colombo C, Group LS. Caregiver burden and vocational participation among parents of adolescents with CF. Pediatr Pulmonol. 2016;51(3):243–52. https://doi.org/10.1002/ppul.23352.

    Article  PubMed  Google Scholar 

  68. Schechter MS, Cruz I, Blackwell LS, Quittner AL. Risk factors for anxiety and depression in cystic fibrosis. Pediatr Pulmonol. 2010;45(Suppl 33):109–10.

    Google Scholar 

  69. Besier T, Goldbeck L. Anxiety and depression in adolescents with CF and their caregivers. J Cyst Fibros. 2011;10(6):435–42. https://doi.org/10.1016/j.jcf.2011.06.012.

    Article  PubMed  Google Scholar 

  70. Yohannes AM, Willgoss TG, Fatoye FA, Dip MD, Webb K. Relationship between anxiety, depression, and quality of life in adult patients with cystic fibrosis. Respir Care. 2012;57(4):550–6. https://doi.org/10.4187/respcare.01328.

    Article  PubMed  Google Scholar 

  71. Quittner AL, Schechter MS, Rasouliyan L, Haselkorn T, Pasta DJ, Wagener JS. Impact of socioeconomic status, race, and ethnicity on quality of life in patients with cystic fibrosis in the United States. Chest. 2010;137(3):642–50. https://doi.org/10.1378/chest.09-0345.

    Article  PubMed  Google Scholar 

  72. Foster C, Eiser C, Oades P, et al. Treatment demands and differential treatment of patients with cystic fibrosis and their siblings: patient, parent and sibling accounts. Child Care Health Dev. 2001;27(4):349–64.

    CAS  PubMed  Google Scholar 

  73. Barker DH, Driscoll KA, Modi AC, Light MJ, Quittner AL. Supporting cystic fibrosis disease management during adolescence: the role of family and friends. Child Care Health Dev. 2012;38(4):497–504. https://doi.org/10.1111/j.1365-2214.2011.01286.x.

    Article  CAS  PubMed  Google Scholar 

  74. Reynolds N, Mrug S, Britton L, Guion K, Wolfe K, Gutierrez H. Spiritual coping predicts 5-year health outcomes in adolescents with cystic fibrosis. J Cyst Fibros. 2014;13(5):593–600. https://doi.org/10.1016/j.jcf.2014.01.013.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Goldman DP, Smith JP. Can patient self-management help explain the SES health gradient? Proc Natl Acad Sci U S A. 2002;99(16):10929–34. https://doi.org/10.1073/pnas.162086599.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  76. Apter AJ, Reisine ST, Affleck G, Barrows E, ZuWallack RL. Adherence with twice-daily dosing of inhaled steroids. Socioeconomic and health-belief differences. Am J Respir Crit Care Med. 1998;157(6 Pt 1):1810–7. https://doi.org/10.1164/ajrccm.157.6.9712007.

    Article  CAS  PubMed  Google Scholar 

  77. Rapoff MA, Belmont JM, Lindsley CB, Olson NY. Electronically monitored adherence to medications by newly diagnosed patients with juvenile rheumatoid arthritis. Arthritis Rheum. 2005;53(6):905–10. https://doi.org/10.1002/Art.21603.

    Article  PubMed  Google Scholar 

  78. Pendleton DA, David TJ. The compliance conundrum in cystic fibrosis. J R Soc Med. 2000;93(Suppl 38):9–13.

    PubMed  PubMed Central  Google Scholar 

  79. Schechter MS. Non-genetic influences on cystic fibrosis lung disease: the role of sociodemographic characteristics, environmental exposures, and healthcare interventions. Semin Respir Crit Care Med. 2003;24(6):639–52. https://doi.org/10.1055/s-2004-815660.

    Article  PubMed  Google Scholar 

  80. Ievers CE, Brown RT, Drotar D, Caplan D, Pishevar BS, Lambert RG. Knowledge of physician prescriptions and adherence to treatment among children with cystic fibrosis and their mothers. J Dev Behav Pediatr. 1999;20(5):335–43.

    CAS  PubMed  Google Scholar 

  81. Lask B. Non-adherence to treatment in cystic fibrosis. J R Soc Med. 1994;87:25–7.

    PubMed  PubMed Central  Google Scholar 

  82. Quittner AL, Drotar D, Ievers-Landis C. Adherence to medical treatments in adolescents with cystic fibrosis: the development and evaluation of family based interventions. In: Drotar D, editor. Promoting adherence to medical treatment in childhood chronic illness: concepts, methods, and interventions. Erlbaum Associates, Inc: Hillsdale; 2000.

    Google Scholar 

  83. Cystic Fibrosis Foundation Patient Registry. 2016 annual data report. Bethesda: Cystic Fibrosis Foundation. p. 2017.

    Google Scholar 

  84. The Canadian Cystic Fibrosis Registry. 2016 annual data report. Toronto, ON: Cystic Fibrosis Canada; 2017.

    Google Scholar 

  85. Kopp BT, Nicholson L, Paul G, Tobias J, Ramanathan C, Hayes D Jr. Geographic variations in cystic fibrosis: an analysis of the U.S. CF Foundation Registry. Pediatr Pulmonol. 2015;50(8):754–62. https://doi.org/10.1002/ppul.23185.

    Article  PubMed  Google Scholar 

  86. Hamosh A, FitzSimmons SC, Macek M Jr, Knowles MR, Rosenstein BJ, Cutting GR. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr. 1998;132(2):255–9.

    CAS  PubMed  Google Scholar 

  87. Kopp BT, Nicholson L, Paul G, Tobias J, Ramanathan C, Hayes D Jr. The geographic impact on hospitalization in patients with cystic fibrosis. J Pediatr. 2016;170:246–52.e1-4. https://doi.org/10.1016/j.jpeds.2015.11.012.

    Article  PubMed  Google Scholar 

  88. Buu MC, Sanders LM, Mayo JA, Milla CE, Wise PH. Assessing differences in mortality rates and risk factors between hispanic and non-hispanic patients with cystic fibrosis in California. Chest. 2016;149(2):380–9. https://doi.org/10.1378/chest.14-2189.

    Article  PubMed  PubMed Central  Google Scholar 

  89. Rho J, Ahn C, Gao A, Sawicki GS, Keller A, Jain R. Disparities in mortality of hispanic patients with cystic fibrosis in the United States. A National and Regional Cohort Study. Am J Respir Crit Care Med. 2018;198(8):1055–63. https://doi.org/10.1164/rccm.201711-2357OC.

    Article  PubMed  PubMed Central  Google Scholar 

  90. McGarry ME, McColley SA. Minorities are underrepresented in clinical trials of pharmaceutical agents for cystic fibrosis. Ann Am Thorac Soc. 2016;13(10):1721–5. https://doi.org/10.1513/AnnalsATS.201603-192BC.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Ross LF. Newborn screening for cystic fibrosis: a lesson in public health disparities. J Pediatr. 2008;153(3):308–13. https://doi.org/10.1016/j.jpeds.2008.04.061.

    Article  PubMed  PubMed Central  Google Scholar 

  92. Smedley BD, Stith AY, Nelson AR, Institute of Medicine (U.S.). Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Unequal treatment: confronting racial and ethnic disparities in health care. Washington, DC: National Academy Press; 2003.

    Google Scholar 

  93. Schechter MS, McColley SA, Silva S, et al. Association of socioeconomic status with the use of chronic therapies and healthcare utilization in children with cystic fibrosis. J Pediatr. 2009;155(5):634–9.e1-4. https://doi.org/10.1016/j.jpeds.2009.04.059.

    Article  PubMed  PubMed Central  Google Scholar 

  94. Schechter MS, McColley SA, Regelmann W, et al. Socioeconomic status and the likelihood of antibiotic treatment for signs and symptoms of pulmonary exacerbation in children with cystic fibrosis. J Pediatr. 2011;159(5):819–24. e1. https://doi.org/10.1016/j.jpeds.2011.05.005.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Li SS, Hayes D Jr, Tobias JD, Morgan WJ, Tumin D. Health insurance and use of recommended routine care in adults with cystic fibrosis. Clin Respir J. 2018;12(5):1981–8. https://doi.org/10.1111/crj.12767.

    Article  PubMed  Google Scholar 

  96. Tuchman LK, Schwartz LA, Sawicki GS, Britto MT. Cystic fibrosis and transition to adult medical care. Pediatrics. 2010;125(3):566–73. https://doi.org/10.1542/peds.2009-2791.

    Article  PubMed  Google Scholar 

  97. Stephenson A, Hux J, Tullis E, Austin PC, Corey M, Ray J. Socioeconomic status and risk of hospitalization among individuals with cystic fibrosis in Ontario. Canada Pediatr Pulmonol. 2011;46(4):376–84. https://doi.org/10.1002/ppul.21368.

    Article  PubMed  Google Scholar 

  98. Ramos KJ, Quon BS, Psoter KJ, et al. Predictors of non-referral of patients with cystic fibrosis for lung transplant evaluation in the United States. J Cyst Fibros. 2016;15(2):196–203. https://doi.org/10.1016/j.jcf.2015.11.005.

    Article  PubMed  Google Scholar 

  99. Quon BS, Psoter K, Mayer-Hamblett N, Aitken ML, Li CI, Goss CH. Disparities in access to lung transplantation for patients with cystic fibrosis by socioeconomic status. Am J Respir Crit Care Med. 2012;186(10):1008–13. https://doi.org/10.1164/rccm.201205-0949OC.

    Article  PubMed  PubMed Central  Google Scholar 

  100. Krivchenia K, Tumin D, Tobias JD, Hayes D Jr. Increased mortality in adult cystic fibrosis patients with Medicaid insurance awaiting lung transplantation. Lung. 2016;194(5):799–806. https://doi.org/10.1007/s00408-016-9927-7.

    Article  CAS  PubMed  Google Scholar 

  101. Merlo CA, Clark SC, Arnaoutakis GJ, et al. National healthcare delivery systems influence lung transplant outcomes for cystic fibrosis. Am J Transplant. 2015;15(7):1948–57. https://doi.org/10.1111/ajt.13226.

    Article  CAS  PubMed  Google Scholar 

  102. Stephenson AL, Sykes J, Stanojevic S, et al. Survival comparison of patients with cystic fibrosis in Canada and the United States: a population-based cohort study. Ann Intern Med. 2017;166(8):537–46. https://doi.org/10.7326/M16-0858.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Stankiewicz A, Herel M, DesMeules M. Report summary–Rio political declaration on social determinants of health: a snapshot of Canadian actions 2015. Health Promot Chronic Dis Prev Can. 2015;35(7):113–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Sharma D, Xing S, Hung YT, Caskey RN, Dowell ML, Touchette DR. Cost-effectiveness analysis of lumacaftor and ivacaftor combination for the treatment of patients with cystic fibrosis in the United States. Orphanet J Rare Dis. 2018;13(1):172. https://doi.org/10.1186/s13023-018-0914-3.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Grosse SD, Do TQN, Vu M, Feng LB, Berry JG, Sawicki GS. Healthcare expenditures for privately insured US patients with cystic fibrosis, 2010–2016. Pediatr Pulmonol. 2018;53(12):1611–8. https://doi.org/10.1002/ppul.24178.

    Article  PubMed  PubMed Central  Google Scholar 

  106. Hyde R, Dobrovolny D. Orphan drug pricing and payer management in the United States: are we approaching the tipping point? Am Health Drug Benefits. 2010;3(1):15–23.

    PubMed  PubMed Central  Google Scholar 

  107. Kanavos P, Nicod E. What is wrong with orphan drug policies? Suggestions for ways forward. Value Health. 2012;15(8):1182–4. https://doi.org/10.1016/j.jval.2012.08.2202.

    Article  PubMed  Google Scholar 

  108. Schechter MS. Nongenetic influences on cystic fibrosis outcomes. Curr Opin Pulm Med. 2011;17(6):448–54. https://doi.org/10.1097/MCP.0b013e32834ba899.

    Article  PubMed  Google Scholar 

  109. Rubin BK. Exposure of children with cystic fibrosis to environmental tobacco smoke. N Engl J Med. 1990;323(12):782–8. https://doi.org/10.1056/NEJM199009203231203.

    Article  CAS  PubMed  Google Scholar 

  110. Schechter M, Emerson J, Rosenfeld M. The relationship of socioeconomic status and environmental tobacco smoke exposure with disease outcomes in the EPIC observational cohort. Pediatr Pulmonol. 2012;47(S35):379.

    Google Scholar 

  111. Ong T, Schechter M, Yang J, et al. Socioeconomic status, smoke exposure, and health outcomes in young children with cystic fibrosis. Pediatrics. 2017;139(2) https://doi.org/10.1542/peds.2016-2730.

  112. Wheeler BW, Ben-Shlomo Y. Environmental equity, air quality, socioeconomic status, and respiratory health: a linkage analysis of routine data from the Health survey for England. J Epidemiol Community Health. 2005;59(11):948–54. https://doi.org/10.1136/jech.2005.036418.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Ard K. Trends in exposure to industrial air toxins for different racial and socioeconomic groups: a spatial and temporal examination of environmental inequality in the U.S. from 1995 to 2004. Soc Sci Res. 2015;53:375–90. https://doi.org/10.1016/j.ssresearch.2015.06.019.

    Article  PubMed  Google Scholar 

  114. Deguen S, Petit C, Delbarre A, et al. Neighbourhood characteristics and long-term air pollution levels modify the association between the short-term nitrogen dioxide concentrations and all-cause mortality in Paris. PLoS One. 2015;10(7):e0131463. https://doi.org/10.1371/journal.pone.0131463.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Gauderman WJ, Avol E, Gilliland F, et al. The effect of air pollution on lung development from 10 to 18 years of age. N Engl J Med. 2004;351(11):1057–67. https://doi.org/10.1056/NEJMoa040610.

    Article  CAS  PubMed  Google Scholar 

  116. Pope CA, Thun MJ, Namboodiri MM, et al. Particulate air-pollution as a predictor of mortality in a prospective-study of us adults. Am J Respir Crit Care Med. 1995;151(3):669–74.

    PubMed  Google Scholar 

  117. Goeminne PC, Kicinski M, Vermeulen F, et al. Impact of air pollution on cystic fibrosis pulmonary exacerbations: a case-crossover analysis. Chest. 2013;143(4):946–54. https://doi.org/10.1378/chest.12-1005.

    Article  CAS  PubMed  Google Scholar 

  118. Goss CH, Newsom SA, Schildcrout JS, Sheppard L, Kaufman JD. Effect of ambient air pollution on pulmonary exacerbations and lung function in cystic fibrosis. Am J Respir Crit Care Med. 2004;169(7):816–21. https://doi.org/10.1164/rccm.200306-779OC.

    Article  PubMed  Google Scholar 

  119. Psoter KJ, De Roos AJ, Mayer JD, Kaufman JD, Wakefield J, Rosenfeld M. Fine particulate matter exposure and initial Pseudomonas aeruginosa acquisition in cystic fibrosis. Ann Am Thorac Soc. 2015;12(3):385–91. https://doi.org/10.1513/AnnalsATS.201408-400OC.

    Article  PubMed  Google Scholar 

  120. Kosorok MR, Zeng L, West SE, et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol. 2001;32(4):277–87.

    CAS  PubMed  Google Scholar 

  121. Nixon GM, Armstrong DS, Carzino R, et al. Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. J Pediatr. 2001;138(5):699–704. https://doi.org/10.1067/mpd.2001.112897.

    Article  CAS  PubMed  Google Scholar 

  122. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34(2):91–100. https://doi.org/10.1002/ppul.10127.

    Article  PubMed  Google Scholar 

  123. Li Z, Kosorok MR, Farrell PM, et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. JAMA. 2005;293(5):581–8. https://doi.org/10.1001/jama.293.5.581.

    Article  CAS  PubMed  Google Scholar 

  124. Kosorok MR, Jalaluddin M, Farrell PM, et al. Comprehensive analysis of risk factors for acquisition of Pseudomonas aeruginosa in young children with cystic fibrosis. Pediatr Pulmonol. 1998;26(2):81–8.

    CAS  PubMed  Google Scholar 

  125. Goldhagen J, Remo R, Bryant T 3rd, et al. The health status of southern children: a neglected regional disparity. Pediatrics. 2005;116(6):e746–53. https://doi.org/10.1542/peds.2005-0366.

    Article  PubMed  Google Scholar 

  126. Collaco JM, McGready J, Green DM, et al. Effect of temperature on cystic fibrosis lung disease and infections: a replicated cohort study. PLoS One. 2011;6(11):e27784. https://doi.org/10.1371/journal.pone.0027784.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  127. Collaco JM, Raraigh KS, Appel LJ, Cutting GR. Respiratory pathogens mediate the association between lung function and temperature in cystic fibrosis. J Cyst Fibros. 2016;15(6):794–801. https://doi.org/10.1016/j.jcf.2016.05.012.

    Article  PubMed  PubMed Central  Google Scholar 

  128. Vahedi L, Jabarpoor-Bonyadi M, Ghojazadeh M, Hazrati H, Rafeey M. Association between outcomes and demographic factors in an Azeri Turkish population with cystic fibrosis: a cross-sectional study in Iran from 2001 through 2014. Iran Red Crescent Med J. 2016;18(4):e29615. https://doi.org/10.5812/ircmj.29615.

    Article  PubMed  PubMed Central  Google Scholar 

  129. Thomas CL, O'Rourke PK, Wainwright CE. Clinical outcomes of Queensland children with cystic fibrosis: a comparison between tertiary centre and outreach services. Med J Aust. 2008;188(3):135–9.

    PubMed  Google Scholar 

  130. Wood J, Mulrennan S, Hill K, Cecins N, Morey S, Jenkins S. Telehealth clinics increase access to care for adults with cystic fibrosis living in rural and remote Western Australia. J Telemed Telecare. 2017;23(7):673–9. https://doi.org/10.1177/1357633X16660646.

    Article  PubMed  Google Scholar 

  131. Roberts JM, Wilcox PG, Quon BS. Evaluating adult cystic fibrosis care in BC: disparities in access to a multidisciplinary treatment Centre. Can Respir J. 2016;2016:8901756. https://doi.org/10.1155/2016/8901756.

    Article  PubMed  PubMed Central  Google Scholar 

  132. The Brazilian Cystic Fibrosis Patient Registry 2015; 2016.

    Google Scholar 

  133. Mehta G, Macek M Jr, Mehta A, European Registry Working G. Cystic fibrosis across Europe: EuroCareCF analysis of demographic data from 35 countries. J Cyst Fibros. 2010;9(Suppl 2):S5–S21. https://doi.org/10.1016/j.jcf.2010.08.002.

    Article  PubMed  Google Scholar 

  134. McCormick J, Mehta G, Olesen HV, et al. Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet. 2010;375(9719):1007–13. https://doi.org/10.1016/S0140-6736(09)62161-9.

    Article  PubMed  Google Scholar 

  135. Zolin A, Bossi A, Cirilli N, Kashirskaya N, Padoan R. Cystic fibrosis mortality in childhood. Data from European Cystic Fibrosis Society Patient Registry. Int J Environ Res Public Health. 2018;15(9) https://doi.org/10.3390/ijerph15092020.

  136. Adler NE, Stewart J. Health disparities across the lifespan: meaning, methods, and mechanisms. Ann N Y Acad Sci. 2010;1186:5–23. https://doi.org/10.1111/j.1749-6632.2009.05337.x.

    Article  PubMed  Google Scholar 

  137. Schechter MS. Wealth as a disease modifier in cystic fibrosis. Lancet Respir Med. 2013;1(2):93–5. https://doi.org/10.1016/S2213-2600(13)70014-6.

    Article  PubMed  Google Scholar 

  138. Final Report of the Commission on Social Determinants of Health. Geneva. Geneva, Switzerland World Health Organization; 2008.

    Google Scholar 

  139. Taylor-Robinson D, Schechter MS. Health inequalities and cystic fibrosis. BMJ. 2011;343:d4818. https://doi.org/10.1136/bmj.d4818.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, USA

    Gabriela R. Oates

  2. Division of Pulmonary Medicine, Department of Pediatrics, Virginia Commonwealth University, Children’s Hospital of Richmond at VCU, Richmond, VA, USA

    Michael S. Schechter

Authors
  1. Gabriela R. Oates
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michael S. Schechter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gabriela R. Oates .

Editor information

Editors and Affiliations

  1. The University of North Carolina at Chapel Hill, Department of Pediatrics, UNC Children’s Hospital, Chapel Hill, NC, USA

    Stephanie Duggins Davis

  2. Department of Pediatrics, University of Washington School of Medicine, Division of Pulmonary and Sleep Medicine, Seattle Children’s Hospital, Seattle, WA, USA

    Margaret Rosenfeld

  3. Department of Pediatrics, Indiana University School of Medicine, Division of Pediatric Pulmonology, Allergy and Sleep Medicine, Riley Hospital for Children at IU Health, Indianapolis, IN, USA

    James Chmiel

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Oates, G.R., Schechter, M.S. (2020). Health Disparities. In: Davis, S., Rosenfeld, M., Chmiel, J. (eds) Cystic Fibrosis. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-030-42382-7_3

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-42382-7_3

  • Published:

  • Publisher Name: Humana, Cham

  • Print ISBN: 978-3-030-42381-0

  • Online ISBN: 978-3-030-42382-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation